CRS: BJMC
Position: Communications Associate
CRS: JHU
Position: Multi-media and Technical Specialist
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
